Demographics, Diagnosis, Management, and Outcomes of Non-occlusive Mesenteric Ischemia.

NCT ID: NCT06970015

Last Updated: 2025-05-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

566 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-06-06

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This prospective multicenter observational study, conducted between June , 2022, and April, 2023, is a preplanned analysis of the AMESI study titled 'Demographics, diagnosis, management, and outcomes of non-occlusive mesenteric ischemia,' aiming primarily to describe the demographic profile, clinical presentation, and laboratory findings of patients with non-occlusive mesenteric ischemia (NOMI), and secondarily to identify independent risk factors as well as diagnostic approaches, management strategies, and outcomes-including in-hospital, 90-day, and one-year results.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Non-Occlusive Mesenteric Ischemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with non-occlusive mesenteric ischemia

Patients with non-occlusive mesenteric ischemia, n=55

No intervention

Intervention Type OTHER

No intervention, this is an observational study on patients with suspected acute mesenteric ischemia

Patients with arterial occlusive mesenteric ischemia

Patients with arterial occlusive mesenteric ischemia, n=231

No intervention

Intervention Type OTHER

No intervention, this is an observational study on patients with suspected acute mesenteric ischemia

Patients with venous occlusive mesenteric ischemia

Patients with arterial occlusive mesenteric ischemia, n=73

No intervention

Intervention Type OTHER

No intervention, this is an observational study on patients with suspected acute mesenteric ischemia

Patients with unclear mechanism of acute mesenteric ischemia

Patients with unclear mechanism of acute mesenteric ischemia, n=48

No intervention

Intervention Type OTHER

No intervention, this is an observational study on patients with suspected acute mesenteric ischemia

Patients with suspected but not confirmed acute mesenteric ischemia

Patients with suspected but not confirmed acute mesenteric ischemia, n=159

No intervention

Intervention Type OTHER

No intervention, this is an observational study on patients with suspected acute mesenteric ischemia

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention

No intervention, this is an observational study on patients with suspected acute mesenteric ischemia

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

All at least 18-year-old patients with acute mesenteric ischemia or patients suspected of acute mesenteric ischemia that was not confirmed

* Patients with arterial occlusive AMI
* Patients with non-occlusive mesenteric ischemia
* Patients with venous occlusive AMI
* Patients with unclear mechanism of AMI
* Patients with suspected but not confirmed AMI

Exclusion Criteria

* Patients with other specific form of AMI (e.g dissection)
* Confirmed strangulating bowel obstruction
* Individuals under 18 years of age.
* Consent declined by patient or next of kin
* Chronic mesenteric ischaemia without an acute event
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Tartu

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Vladislav Mihnovitš

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Tartu

Tartu, , Estonia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Estonia

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NOMI-AMESI

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.